These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4722461)

  • 1. Studies on the mechanism of antifolate induced inhibition on HeLa cell growth.
    Pristoupilová K; Hermanová E; Slavík K
    Biochem Pharmacol; 1973 Aug; 22(15):1937-42. PubMed ID: 4722461
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer research: from folate antagonism to molecular targets.
    Bertino JR
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):577-82. PubMed ID: 19959110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase.
    Ercikan E; Waltham M; Dicker A; Schweitzer B; Bertino JR
    Adv Exp Med Biol; 1993; 338():515-9. PubMed ID: 8304170
    [No Abstract]   [Full Text] [Related]  

  • 4. Histochemical pattern of tetrahydrofolate dehydrogenase in hemopoietic cells following folate antagonist treatment in vivo.
    Nano R; Gerzeli G; Gervaso MV; De Piceis Polver P; Arisi C
    Cell Mol Biol Incl Cyto Enzymol; 1979; 24(3):191-7. PubMed ID: 498204
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.
    Sirotnak FM; DeGraw JI; Chello PL; Moccio DM; Dorick DM
    Cancer Treat Rep; 1982 Feb; 66(2):351-8. PubMed ID: 7055818
    [No Abstract]   [Full Text] [Related]  

  • 6. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
    Jackson RC; Niethammer D; Hart LI
    Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential antileprotic agents. 2. Inhibition of mycobacterial dihydrofolic reductase.
    DeGraw JI; Brown VH; Colwell WT; Morrison NE
    J Med Chem; 1974 Jan; 17(1):144-6. PubMed ID: 4585973
    [No Abstract]   [Full Text] [Related]  

  • 8. Conditional antifolate resistance in Bacillus subtilis thyA.
    Farmer JL
    Antimicrob Agents Chemother; 1979 Apr; 15(4):527-34. PubMed ID: 111614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two different effects of mutation on the binding of folate antagonists by a microbial dihydrofolate reductase.
    Sirotnak FM
    Biochim Biophys Acta; 1973 Mar; 302(1):13-23. PubMed ID: 4144236
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues.
    Rosowsky A; Forsch RA; Wright JE
    J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA synthesis as a therapeutic target: the first 65 years.
    Mathews CK
    FASEB J; 2012 Jun; 26(6):2231-7. PubMed ID: 22653564
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular perspective: methotrexate.
    Goodsell DS
    Stem Cells; 1999; 17(5):314-5. PubMed ID: 10527466
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo measurement of dihydrofolate reductase and its inhibition by antifolates.
    Bowers SW; Duch DS
    Anal Biochem; 1988 Jul; 172(1):169-75. PubMed ID: 3189762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifolate activity of isoaminopterin in HeLa cells.
    Rosemond-Hornbeak H; Nair MG
    Antimicrob Agents Chemother; 1979 May; 15(5):730-4. PubMed ID: 525990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analog specific aberrancies in antifolate inhibition of L1210 cell dihydrofolate reductase.
    Sirotnak FM; Chello PL; Moccio DM; Piper JR; Montgomery JA; Parham JC
    Biochem Pharmacol; 1980 Dec; 29(24):3293-8. PubMed ID: 7213404
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 8-deaza-5,6,7,8-tetrahydroaminopterin derivatives as dihydrofolate inhibitor: design, synthesis and antifolate activity.
    Zhang Z; Wu J; Ran F; Guo Y; Tian R; Zhou S; Wang X; Liu Z; Zhang L; Cui J; Liu J
    Eur J Med Chem; 2009 Feb; 44(2):764-71. PubMed ID: 18555562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydrofolate reductase from Trypanosoma equiperdum. I. Isolation, partial purification, and properties.
    Jaffe JJ; McCormack JJ
    Mol Pharmacol; 1967 Jul; 3(4):359-69. PubMed ID: 4382281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.